البلد: قبرص
اللغة: اليونانية
المصدر: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
ISOSORBIDE MONONITRATE
TOPRIDGE PHARMA (IRELAND) LIMITED (0000010452) 6-9 TRINITY STREET, DUBLIN 2, D02EY47
C01DA14
ISOSORBIDE MONONITRATE
60MG
PROLONGED RELEASE TABLETS
ISOSORBIDE MONONITRATE (0016051777) 60MG
ORAL USE
Εθνική Διαδικασία
ISOSORBIDE MONONITRATE
Νομικό καθεστώς: Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 28 TABS IN BLISTER(S) (880027902) 28 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται
ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ IMDUR DURULES 60 MG PATIENT INFORMATION LEAFLET IMDUR DURULES 60 MG ΔΙΑΒΆΣΤΕ ΜΕ ΠΡΟΣΟΧΉ ΑΥΤΌ ΤΟ ΦΥΛΛΆΔΙΟ ΠΡΙΝ ΠΆΡΕΤΕ ΑΥΤΌ ΤΟ ΦΆΡΜΑΚΟ. Φυλάξτε αυτό το φυλλάδιο. Ίσως χρειαστεί να το διαβάσετε ξανά. Αν έχετε άλλες απορίες, ρωτήστε το γιατρό ή το φαρμακοποιό σας. Αυτό το φάρμακο έχει συνταγογραφηθεί για σας προσωπικά και δεν πρέπει να το δώσετε σε άλλους. Μπορεί να τους προκαλέσει βλάβη, ακόμα και αν έχουν τα ίδια συμπτώματα με εσάς. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have further questions, please ask your doctor or your pharmacist. This medicine has been prescribed for you personally and you should not pass it on to others. It may harm them, even if their symptoms are the same as yours. ΜΕ ΤΟ ΠΑΡΌΝ ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ ΘΑ ΕΝΗΜΕΡΩΘΕΊΤΕ ΓΙΑ ΤΑ ΑΚΌΛΟΥΘΑ 1. Τι είναι το Imdur Durules και ποιά είναι η χρήση του 2. Τι πρέπει να γνωρίζετε προτού πάρετε το Imdur Durules 3. Πώς να πάρετε το Imdur Durules 4. Πιθανές παρενέργειες 5. Φύλαξη του Imdur Durules 6. Άλλες πληροφορίες IN THIS LEAFLET 1. What Imdur Durules is and what it is used for 2. Before you take Imdur Durules 3. How to take Imdur Durules 4. Possible side effects 5. Storing Imdur Durules 6. Further information Το δραστικό συστατικό είναι το isosorbide-5-mononitrate. Τα άλλα συστατικά είναι: sodium aluminium silicate, paraffin, hydroxypropyl cellulose, magnesium stearate, colloidal silicon dioxide, h اقرأ الوثيقة كاملة
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Imdur® 60 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains isosorbide-5-mononitrate 60 mg in a prolonged release formulation - Durules®. For excipients see ”List of excipients”. 3. PHARMACEUTICAL FORM Imdur Durules 60 mg is yellow, oval, scored, marked A/ID, 7 x 13 mm. The Durules formulation provides gradual release of the active ingredient over a long period of time. The plastic matrix in Imdur Durules is completely inert in the digestive juice but generally disintegrates under the influence of intestinal peristalsis when all active ingredient has been released. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prophylactic treatment of angina pectoris. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION 60 mg once daily to be taken in the morning. The dose may be increased to 120 mg daily, taken once daily in the morning. The dose can be titrated to minimize the possibility of headache by initiating treatment with 30 mg for the first 2-4 days. The tablets can be taken with or without food. The 60mg depottablets are scored and dividable. The whole tablets or if needed the divided halves, should not be chewed or crushed and should be swallowed together with half a glass of fluid. Imdur is not indicated for the relief of acute attacks. In these situations sublingual or buccal nitroglycerine tablets or spray formulations should be used. Children The safety and efficacy of Imdur in children has not been established. Elderly No evidence of a need for routine dosage adjustment in the elderly has been found, but special care may be needed in those with increased susceptibility to hypotension or marked hepatic or renal insufficiency. - 1 - The matrix of the tablet is insoluble but disintegrates when the active substance is released. Occasionally the matrix may pass through the gastrointestinal tract without disintegrating and may be visible in the stool but this does not indicate that the drug has had a reduced effect. 4.3 CONTRAINDICA اقرأ الوثيقة كاملة